PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Cyclopentolate hydrochloride - Iritis

PAD Profile : Cyclopentolate hydrochloride - Iritis

Keywords :
eye drops, minims
Brand Names Include :
Mydrilate

Traffic Light Status

Status 1 of 1.

Status :
Red
Important
Formulations :
  • Eye drops
  • Eye drops (preservative free, unit dose)
Important Information :
eye drops 0.5%, 1%
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
05 September 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network recommends the use of cyclopentolate eye drops (0.5% & 1%) for the treatment licensed hospital indications ( including Iritis and Uveitis)

Cyclopentolate eye drops will be considered to be RED on the traffic light system.

New patients should be initiated on cyclopentolate eye drops by their consultant ophthalmologist.

Associated BNF Codes

11. Eye
11.05.00. Mydriatics and cycloplegics
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More